Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
Clinical trial NCT01279590 · COMPLETED
Trial details
- NCT number
- NCT01279590
- Sponsor
- Furiex Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-11-01
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.